Prolongation of canine renal allograft survival by treatment with FK-506.
D000284:Administration, Oral; D000818:Animals; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D005260:Female; D006085:Graft Survival / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D007273:Injections, Intramuscular; D016030:Kidney Transplantation; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D013268:Stimulation, Chemical; D016559:Tacrolimus
D007166:Immunosuppressive Agents; D011725:Pyridines; D016559:Tacrolimus